Explore Watchlists Pricing

KISSEI PHARMACEUTICAL CO.,LTD. (4547) Balance sheet

Market cap

¥185.7B

P/E ratio

10.9x

Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	27,241	25,666	27,109	24,371	26,325	36,329	20,456	30,013	25,893	22,894	25,169	29,057
Marketable securities, current	-	25,132	24,476	21,039	23,288	23,039	23,342	23,998	23,139	23,706	23,039	23,485	25,367
Accounts receivable, net	-	23,675	24,966	24,730	28,873	26,963	19,462	23,058	-	-	-	-	-
Inventories	-	6,027	5,980	5,504	4,933	5,847	6,926	11,066	10,491	12,679	14,310	13,706	12,463
Total current assets	-	97,361	100,051	97,218	100,599	95,782	96,677	92,965	99,342	100,641	104,551	106,980	114,969
Property, plant and equipment, net	-	26,852	26,758	26,308	26,396	25,503	24,605	24,290	24,074	24,579	24,861	27,069	28,093
Marketable securities, non-current	-	54,382	62,300	58,344	81,194	86,958	105,158	138,133	96,631	74,769	106,361	84,869	104,271
Total non-current assets	-	84,122	93,294	89,582	112,487	117,739	135,117	175,895	138,745	120,558	156,377	137,079	160,117
Total assets	-	181,484	193,345	186,801	213,087	213,522	231,794	268,861	238,087	221,200	260,929	244,059	275,086
Accounts payable	-	6,045	5,829	4,849	4,894	4,347	5,237	7,909	4,104	4,617	4,893	4,602	6,661
Short-term debt	-	1,815	1,815	1,800	1,757	1,764	1,746	1,743	1,640	1,490	1,340	1,280	1,250
Total current liabilities	-	18,934	19,608	15,656	17,448	13,801	17,024	18,245	18,744	14,957	17,663	16,578	21,688
Total non-current liabilities	-	11,829	15,612	13,361	19,546	17,013	21,800	30,662	17,163	11,428	22,129	17,354	21,862
Total liabilities	-	30,764	35,220	29,017	36,994	30,814	38,824	48,907	35,907	26,385	39,793	33,933	43,550
Retained earnings	-	95,565	96,230	101,755	102,834	106,026	106,461	109,270	118,183	125,576	127,310	131,488	136,253
Stockholders' equity	142,821	150,720	158,125	157,783	176,092	182,707	192,970	219,953	202,180	194,814	221,136	210,126	231,536
Working capital	-								-	-	-	-	-